FDA Inspection 1197504 — Johan A. Maertens, M.D.

Johan A. Maertens, M.D. — FEI 3012220002

The FDA completed an inspection of Johan A. Maertens, M.D. on January 27, 2023 in Leuven. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 27, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Leuven (Belgium)

Additional Details

Clinical Investigator (CI)